EX-99.1
6
pressrelease.htm
PRESS RELEASE DATED 10/6/04
Press Release dated 10/6/04
Investors/Corporate:
John
Emery, CFO
Ventiv
Health, Inc.
732-537-4804
investor@ventiv.com
Media:
Kellie
Walsh / Felicia Vonella
Lazar
Partners Ltd.
212-867-1762
kwalsh@lazarpartners.com
/
fvonella@lazarpartners.com
Ventiv
Health Completes Acquisition of inChord Communications
Blane
Walter and Terry Herring join Ventiv Board of
Directors
SOMERSET,
N.J., October 6, 2005 - Ventiv Health, Inc. (NASDAQ: VTIV) today announced
the
completion of its acquisition of inChord Communications, Inc., the world's
largest independently-owned global healthcare marketing and communications
company.
Ventiv
announced on September 7, 2005 that it would acquire inChord for $185 million
in
cash and stock, plus closing adjustments and earn-out payments for exceeding
specified financial targets. In conjunction with the closing inChord becomes
a
wholly owned subsidiary of Ventiv Health, and will continue to operate under
the
inChord Communications brand.
Effective
today, Blane Walter, CEO of inChord, and Terrell Herring, President and COO
of
Ventiv Commercial Services, have also joined Ventiv's Board of Directors,
increasing the size of the Board to nine Directors.
Eran
Broshy, CEO of Ventiv stated, "We are excited to welcome Blane and the whole
inChord team into the Ventiv family. This combination further establishes Ventiv
as a powerful market leader in pharmaceutical commercialization services and
effectively positions us to develop unique solutions for our clients' business
challenges. I am also delighted to welcome both Blane and Terry to Ventiv's
Board of Directors. Their industry perspective and managerial expertise are
invaluable and will play a key role as we continue to build
Ventiv."
2
About
Ventiv Health
Ventiv
Health, Inc. (NASDAQ: VTIV) is the leading provider of commercialization
services to the global pharmaceutical and lifesciences industries. Ventiv
delivers its customized clinical, sales, marketing and communications services
through its three core business segments: Commercial Services, Clinical Services
and Communications Services. Ventiv's 4,600 employees support over 150 client
organizations, including 18 of the Top 20 global pharmaceutical companies as
well as emerging and specialty biotech leaders. For more information on Ventiv
Health, Inc. visit www.ventiv.com.
This
press release contains forward-looking statements within the meaning of the
Private Securities Litigation Reform Act of 1995. Such forward-looking
statements involve known and unknown risks that may cause Ventiv Health's
performance to differ materially. Such risks include, without limitation:
changes in trends in the pharmaceutical industry or in pharmaceutical
outsourcing; our ability to compete successfully with other services in the
market; our ability to maintain large client contracts or to enter into new
contracts; uncertainties related to future incentive payments; and, our ability
to operate successfully in new lines of business. Readers of this press release
are referred to documents filed from time to time by Ventiv Health Inc. with
the
Securities and Exchange Commission for further discussion of these and other
factors
.
###

EX - 99 . 1 6 pressrelease . htm PRESS RELEASE DATED 10 / 6 / 04 Press Release dated 10 / 6 / 04 Investors / Corporate : John Emery , CFO Ventiv Health , Inc . 732 - 537 - 4804 investor@ventiv.com Media : Kellie Walsh / Felicia Vonella Lazar Partners Ltd . 212 - 867 - 1762 kwalsh@lazarpartners.com / fvonella@lazarpartners.com Ventiv Health Completes Acquisition of inChord Communications Blane Walter and Terry Herring join Ventiv Board of Directors SOMERSET , N . J . , October 6 , 2005 - Ventiv Health , Inc . ( NASDAQ : VTIV ) today announced the completion of its acquisition of inChord Communications , Inc . , the world 's largest independently - owned global healthcare marketing and communications company . Ventiv announced on September 7 , 2005 that it would acquire inChord for $ 185 million in cash and stock , plus closing adjustments and earn - out payments for exceeding specified financial targets . In conjunction with the closing inChord becomes a wholly owned subsidiary of Ventiv Health , and will continue to operate under the inChord Communications brand . Effective today , Blane Walter , CEO of inChord , and Terrell Herring , President and COO of Ventiv Commercial Services , have also joined Ventiv 's Board of Directors , increasing the size of the Board to nine Directors . Eran Broshy , CEO of Ventiv stated , " We are excited to welcome Blane and the whole inChord team into the Ventiv family . This combination further establishes Ventiv as a powerful market leader in pharmaceutical commercialization services and effectively positions us to develop unique solutions for our clients ' business challenges . I am also delighted to welcome both Blane and Terry to Ventiv 's Board of Directors . Their industry perspective and managerial expertise are invaluable and will play a key role as we continue to build Ventiv . " 2 About Ventiv Health Ventiv Health , Inc . ( NASDAQ : VTIV ) is the leading provider of commercialization services to the global pharmaceutical and lifesciences industries . Ventiv delivers its customized clinical , sales , marketing and communications services through its three core business segments : Commercial Services , Clinical Services and Communications Services . Ventiv 's 4,600 employees support over 150 client organizations , including 18 of the Top 20 global pharmaceutical companies as well as emerging and specialty biotech leaders . For more information on Ventiv Health , Inc . visit www.ventiv.com . This press release contains forward - looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 . Such forward - looking statements involve known and unknown risks that may cause Ventiv Health 's performance to differ materially . Such risks include , without limitation : changes in trends in the pharmaceutical industry or in pharmaceutical outsourcing ; our ability to compete successfully with other services in the market ; our ability to maintain large client contracts or to enter into new contracts ; uncertainties related to future incentive payments ; and , our ability to operate successfully in new lines of business . Readers of this press release are referred to documents filed from time to time by Ventiv Health Inc . with the Securities and Exchange Commission for further discussion of these and other factors . # # #